Cidara Therapeutics Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Cidara Therapeutics Inc
CIK #0001610618
EDGAR Form CIK 2011 - 2026
10-K [0001610618]
10-Q [0001610618]
3 [0001610618]
4 [0001610618]
8-K [0001610618]
D [0001610618]
SC 13D [0001610618]
SC 13G [0001610618]
Form 13D/13G Filer Form 13D/13G Subject Filed
Vanguard Group Inc Cidara Therapeutics Inc [2026-01-30]
Paradigm Biocapital Advisors LP Cidara Therapeutics Inc [2025-07-30]
BlackRock Inc Cidara Therapeutics Inc [2025-07-17]
Commodore Capital LP Cidara Therapeutics Inc [2025-07-02]
Adage Capital Management LP Cidara Therapeutics Inc [2025-05-12]
Point72 Asset Management LP Cidara Therapeutics Inc [2025-04-16]
Vivo Opportunity Fund Holdings LP Cidara Therapeutics Inc [2024-12-09]
Venrock Healthcare Capital Partners III LP Cidara Therapeutics Inc [2024-12-04]
TCG Crossover GP II LLC Cidara Therapeutics Inc [2024-12-03]
BCLS Fund III Investments LP Cidara Therapeutics Inc [2024-07-29]
View All
Form 3/4/5 Subject 2011 - 2026
K2 Therapeutics Inc
Shah Rajeev M
RA Capital Healthcare Fund LP
RA Capital Management LP
Kolchinsky Peter
Burgess Daniel D
Davarpanah Nicole Negar
Canale-Theakston Carin
Spencer Ryan
Resnick Joshua
Bassler Bonnie L
Ward Shane
Stein Jeffrey
Mineo Chrysa
Schroeder Theodore R
Merson James
Karbe Frank
Tari Leslie
Sandison Taylor
Shah Preetam
Tadvalkar Laura
Gollaher David L
Franson Timothy R
Daruwala Paul
Johnson Brady
Abdollahian Neil
Oien Jessica
Levine James E
Mundipharma AG
Rocklage Scott M
Onaitis Matthew
BB Biotech AG
Biotech Target N V
Wilson Marc
Perez Robert J
Forrest Kevin
Bartizal Ken
Thye Dirk
Heron Patrick J
Kjellson Nina S
5AM Co-Investors III LP
Diekman John D
Schwab Andrew J
5AM Ventures III LP
Elms Steve
Judice Kevin
Aisling Capital Partners LP
Seachaid Pharmaceuticals Inc
Aisling Capital II LP
Schiff Andrew N
Aisling Capital Partners LLC
Purcell Dennis J
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
K2 Therapeutics Inc CDTX
Stock Option (right to buy) · derivative
2026-01-07 Disposed to issuer 550
K2 Therapeutics Inc CDTX
Stock Option (right to buy) · derivative
2026-01-07 Disposed to issuer 875
K2 Therapeutics Inc CDTX
Stock Option (right to buy) · derivative
2026-01-07 Disposed to issuer 11,100
K2 Therapeutics Inc CDTX
Stock Option (right to buy) · derivative
2026-01-07 Disposed to issuer 11,100
K2 Therapeutics Inc CDTX
Common Stock
2026-01-07 Disposed to issuer 12,553 $221.50 2,780,490
K2 Therapeutics Inc CDTX
Stock Option (right to buy) · derivative
2026-01-07 Disposed to issuer 16,000
K2 Therapeutics Inc CDTX
Stock Option (right to buy) · derivative
2026-01-07 Disposed to issuer 2,125
K2 Therapeutics Inc CDTX
Stock Option (right to buy) · derivative
2026-01-07 Disposed to issuer 1,000
K2 Therapeutics Inc CDTX
Stock Option (right to buy) · derivative
2026-01-07 Disposed to issuer 450
K2 Therapeutics Inc CDTX
Stock Option (right to buy) · derivative
2026-01-07 Disposed to issuer 550
K2 Therapeutics Inc CDTX
Employee Stock Option (right to buy) · derivative
2026-01-07 Disposed to issuer 11,000
K2 Therapeutics Inc CDTX
Employee Stock Option (right to buy) · derivative
2026-01-07 Disposed to issuer 16,499
K2 Therapeutics Inc CDTX
Employee Stock Option (right to buy) · derivative
2026-01-07 Disposed to issuer 30,000
K2 Therapeutics Inc CDTX
Employee Stock Option (right to buy) · derivative
2026-01-07 Disposed to issuer 62,597
K2 Therapeutics Inc CDTX
Common Stock
2026-01-07 Option exercise 1,286,786 $0.00
K2 Therapeutics Inc CDTX
Stock Option (right to buy) · derivative
2026-01-07 Disposed to issuer 1,400
K2 Therapeutics Inc CDTX
Stock Option (right to buy) · derivative
2026-01-07 Disposed to issuer 11,100
K2 Therapeutics Inc CDTX
Stock Option (right to buy) · derivative
2026-01-07 Disposed to issuer 550
K2 Therapeutics Inc CDTX
Stock Option (right to buy) · derivative
2026-01-07 Disposed to issuer 11,100
K2 Therapeutics Inc CDTX
Stock Option (right to buy) · derivative
2026-01-07 Disposed to issuer 550
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com